UBS Group »

Vincera Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Vincera Pharma (VINC) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Vincera Pharma

Tip: Access up to 7 years of quarterly data

All positions including Vincera Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vincera Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5k 2.9k 1.18
2023-09-30 $5.8k 5.7k 1.01
2022-09-30 $2.0k 1.6k 1.28

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Vincera Pharma

Goldman Sachs Group
Sage Rhino Capital
Long Focus Capital Management
Bank of America Corporation
Vanguard Group
Kingdon Capital Management
Point72 Asset Management
Tejara Capital
Citadel Advisors
Walleye Trading Advisors
Schonfeld Strategic Advisors
T. Rowe Price Associates
Millennium Management
GW & Wade
LMR Partners

View all funds holding Vincera Pharma